(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Terapia génica del cáncer > DA - CIMA - Terapia génica y Hepatología - Terapia génica del cáncer - Artículos de revista >

Kinetic and dynamic computational model-based characterization of new proteins in mice: application to interferon alpha linked to apolipoprotein a-I
Autor(es) : Parra-Guillen, Z.P. (Zinnia Patricia)
Fioravanti, J. (Jessica)
Medina-Echeverz, J. (José)
Gomer, C. (Celia)
Ardaiz, N. (Nuria)
Troconiz, I.F. (Iñaki F.)
Berraondo, P. (Pedro)
Palabras clave : Interferon Alpha
Apolipoprotein A-I
Fecha incorporación: 2012
Editorial : Public Library of Science
Versión del editor: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042100
ISSN: 1932-6203
Cita: Parra-Guillen ZP, Fioravanti J, Medina-Echeverz J, Gomar C, Ardaiz N, Troconiz IF, et al. Kinetic and dynamic computational model-based characterization of new proteins in mice: application to interferon alpha linked to apolipoprotein a-I. PLoS One 2012;7(7):e42100.
Resumen
Interferon alpha linked to apolipoprotein A-I has been recently proposed as an improved interferon-based therapy. In the present study, we aimed to develop a computational model to gain further insight into the in vivo behaviour of this new fusion protein. In order to facilitate in vivo evaluation of interferon and the fusion protein without altering their biological properties, green fluorescent protein was incorporated into their structures. Kinetic and dynamic behaviour of both compounds was successfully described after plasmid hydrodynamic administration and in situ synthesis of the studied proteins. Results from the modelling exercise showed that apolipoprotein A-I conferred a modified kinetic behaviour, varying molecule distribution and prolonging half-life without altering liver dynamic performance. However, differences in the gene expression activity were observed at brain level between both compounds. Those differences could be explained by modifications in the dynamic, but also in the biodistribution properties, which would be worth evaluating in future experiments. Therefore, the modelling approach provided a global comprehension of a complex system and allowed us to compare the in vivo behaviour of both compounds and to identify critical aspects that might be important to understand the system better and suggests a need for new model-based experiments.
Enlace permanente: http://hdl.handle.net/10171/23326
Aparece en las colecciones: DA - Farmacia - Tecnología Farmacéutica - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Terapia génica del cáncer - Artículos de revista

Ficheros en este registro:
Fichero:  PlosOne2012_7_7_e42100.pdf
Descripción: 
Tamaño:  471,55 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.